workshop: Global health drug development

TUESDAY, APRIL 4, 2017

The need for innovation in development of and access to healthcare products for global health applications has never been greater, while at the same time the issues facing the developers and manufacturers have never been more complicated.

Developing and distributing medicines and vaccines for a global market involves expanded challenges and issues for the parties involved.  Done well, these developments are smooth alliances between multi-functional organizations funded by both public and private organizations.  Optimally, the resulting products benefit not just traditional markets but also those in less developed countries and regions.  In order to achieve these goals, certain elements are essential:

  • Innovation

  • Development capabilities

  • Funding sources

  • Global clinical trials

  • The strategic and social use of intellectual property

  • Alliance capabilities

  • Distribution networks
     

Join the Global Health Innovation Alliance Accelerator and the Triangle Global Health Consortium on April 4th for a workshop exploring the concerns facing start up companies, spin-offs from universities, institutes, the US government and traditional pharmaceutical companies as they partner to develop and distribute new medicines and vaccines.

 

Attendees will gain practical skills and knowledge on a broad range of issues, including meeting requirements for partnering with the NIH, foundations, and clinical trial organizations; negotiating license agreements; and managing clinical trials in low and middle income countries.  Networking opportunities will be incorporated throughout the day.

Hosted by

Global Health Innovation Alliance Accelerator

Triangle Global Health Consortium

Where

NC Biotech Center

15 TW Alexander Dr, Durham, NC 27703

When

Tuesday, April 4, 9:00am-4:00pm

Cost

Professionals - $65

Students - $40

Agenda

8:30-9:00 AM

Registration

9:00-9:15 AM

Introductions and Welcome

Julie Barnes-Weise, Claire Neal

9:15-9:35 AM

Critical needs in global health development

Chris Woods

9:35-10:05 AM

Vaccine development challenges for emerging diseases

Kevin Gilligan

10:05-10:35 AM

The role of patents in building a building a global health product business

Arles Taylor

10:35-11:00 AM

The impact of the FDA on global health product development through incentives such as the Priority Review Voucher system

Jeffrey Moe

11:00-11:15 AM

Break

11:15-11:45 AM

Life cycle management versus evergreening – how the rest of the world looks at the US and EU pharma market patents.  How will access be addressed?

Rosa Castro

11:45-12:15 PM

Building a sustainable global health business – non-profit or for profit

Rita Khanna

12:15-12:45 PM

Panel: Developing country markets - the economics of partnering a global health product

Rita Khanna and Vishy Pingali

12:45-1:30 PM

Lunch: Federal funding and global health, a look ahead

Greg McDonald

1:30-1:45 PM

Universities as alliance innovators

Mark Crowell

1:45-2:00 PM

The role of a university technology office in finding partners for global health technologies

Robin Rasor

2:00-2:15 PM

The GHIAA Tech Transfer Access to Medicines survey project

Robin Rasor and Kushal Kadakia

2:15-2:45 PM

Ownership of data in a global licensing and development agreement

Julie Watson

2:45-3:05 PM

Alliances for increasing access to medicines for outbreaks and less developed countries

Julie Barnes-Weise

3:05-3:20 PM

Break

3:20-3:40 PM

Bringing global technologies home – licensing with an international institute

Kevin Boggs

3:40-4:10 PM

Panel: Global health licensing

Julie Barnes-Weise, Kevin Boggs, Mark Crowell, Julie Watson

4:10-4:30 PM

Q&A and conclusions

SPEAKERS

Julia Barnes-Weise
Julia Barnes-Weise

Executive Director of Global Health Innovation Alliance Accelerator

press to zoom
Kevin Boggs
Kevin Boggs

Senior Manager of Global Licensing, Research Triangle Institute

press to zoom
Rosa Castro
Rosa Castro

Postdoctoral Associate, Duke Science and Society

press to zoom
Mark Crowell
Mark Crowell

Principal, Academy Innovation Advisors

press to zoom
Kevin Gilligan
Kevin Gilligan

Senior Scientific Advisor at Clinical Research Management, Inc. (ClinicalRM)

press to zoom
Kushal Kadakia
Kushal Kadakia

Student Member, Global Health Innovation Alliance Accelerator

press to zoom
Rita Khanna
Rita Khanna
press to zoom
Greg McDonald
Greg McDonald

Vice President of Government Relations, RTI International

press to zoom
Jeffrey Moe
Jeffrey Moe

Professor of the Practice of Global Health, Duke Global Health Institute

press to zoom
Vishy Pingali
Vishy Pingali

2016-17 George C. Lamb, Jr. Regulatory Fellow at the Kenan Institute for Ethics, Duke University

press to zoom
Robin Rasor
Robin Rasor

‎Executive Director, Office of Licensing and Ventures, Duke University

press to zoom
Arles A. Taylor, Jr.
Arles A. Taylor, Jr.

‎Principal at Jenkins, Wilson, Taylor, & Hunt, P.A.

press to zoom
Julie M. Watson
Julie M. Watson

Special Counsel, Marshall, Gerstein

press to zoom
Chris Woods
Chris Woods

Professor of Medicine and Global Health and Director of Graduate Studies, Duke Global Health Institute

press to zoom

THANK YOU TO OUR SPONSORS

press to zoom
press to zoom